apomorphine has been researched along with Fibrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersohn, F; Garbe, E | 1 |
| Cheng, B; Hu, LQ; Hu, WL; Li, SW; Song, J; Tian, BC; Zheng, XM | 1 |
2 other study(ies) available for apomorphine and Fibrosis
| Article | Year |
|---|---|
Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonists.
Topics: Aged; Aged, 80 and over; Apomorphine; Benzothiazoles; Bromocriptine; Cabergoline; Databases, Factual; Dopamine Agonists; Endomyocardial Fibrosis; Ergolines; Female; Fibrosis; Heart Valve Diseases; Humans; Indoles; Male; Middle Aged; Pergolide; Pericarditis; Pleural Diseases; Pramipexole; Pulmonary Fibrosis; Retroperitoneal Fibrosis; Tetrahydronaphthalenes; Thiophenes; United States | 2009 |
Fibrosis of corpus cavernosum in animals following cavernous nerve ablation.
Topics: Actins; Animals; Apomorphine; Blotting, Western; Collagen; DNA Primers; Dopamine Agonists; Fibrosis; Fluorescent Dyes; Male; Muscle Denervation; Muscle, Smooth; Penile Erection; Penis; Prostatectomy; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2004 |